We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Livanova | LSE:LIVN | London | Ordinary Share | GB00BYMT0J19 | ORD GBP1.00 (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 50.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMLIVN
3 April 2017
Total Voting Rights and Share Capital
In accordance with Disclosure and Transparency Rule 5.6, LivaNova PLC (the "Company") hereby notifies the market that as of 31 March 2017, the Company's capital consists of 48,184,737 ordinary shares of GBP1.00 each. The Company does not hold any shares in treasury.
Therefore, the total number of voting rights in the Company is 48,184,737. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interests in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. LivaNova's advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. Headquartered in London and with a presence in more than 100 countries worldwide, the company employs approximately 4,600 employees.
LivaNova operates as three business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm Management, with operating headquarters in Mirandola (Italy), Houston (U.S.A.) and Clamart (France), respectively.
For more information, please visit www.livanova.com, or contact:
Catherine Moroz
Company Secretary
Phone: +44 (0) 203 325 0662
e-mail: company.secretariat@livanova.com
Karen King
Vice President, Investor Relations & Corporate Communications
Phone: +1 (281) 228-7262
Email: corporate.communications@livanova.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170403005548/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
April 03, 2017 03:21 ET (07:21 GMT)
1 Year Livanova Chart |
1 Month Livanova Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
